Karachi: Hoechst Pakistan Limited, formerly known as Sanofi-Aventis Pakistan Limited, held its Annual General Meeting (AGM) on April 8, 2025, in Karachi and via video link, where shareholders approved several key financial resolutions.

During the AGM, the minutes from the 56th Annual General Meeting, held on April 8, 2024, were confirmed by the shareholders. Additionally, the audited financial statements for the year ending December 31, 2024, were reviewed and adopted. These statements were accompanied by the Chairman's Review, Directors', and Auditors' reports, providing a comprehensive overview of the company's financial performance.

One of the significant resolutions passed was the approval of a final cash dividend of Rs. 110.00 per ordinary share at a rate of 1,100%. This dividend is in addition to an interim cash dividend of Rs. 25.00 per share, representing a 250% payout that was distributed earlier in the year. Shareholders on the company's register as of April 1, 2025, are eligible to receive this final dividend.

A resolution to appoint external auditors for the fiscal year 2025 was also approved. M/s. A.F. Ferguson and Co., Chartered Accountants, were reappointed as the auditors, with their remuneration to be agreed upon with the company's management. The decision was made in line with the recommendations of the Board of Directors.

According to information available from the Pakistan Stock Exchange (PSX), these resolutions align with the regulatory requirements and demonstrate the company's commitment to transparency and shareholder value. The designated market category for Hoechst Pakistan Limited remains unchanged following these resolutions.

The meeting concluded with an emphasis on the company's financial health and strategic direction, as indicated by the approved resolutions and reports.